2025 American Academy of Neurology Abstract Website

Disclosures for "The use of the Traffic Light of Migraine Action Plan (TRALI-MAP) in Acute Migraine Treatment"

Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Searchlight. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Lagman-Bartolome has received research support from AMGEN. The institution of Dr. Lagman-Bartolome has received research support from Abbvie. The institution of Dr. Lagman-Bartolome has received research support from Lundbeck. Dr. Lagman-Bartolome has received publishing royalties from a publication relating to health care.
Dr. Im has nothing to disclose.
The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Mr. Stanaitis has nothing to disclose.
Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Lay has received research support from Teva. The institution of Dr. Lay has received research support from Lundbeck.